Fosen Pharmaceutical (01652.HK): Four products are expected to win bids in the national centralized drug procurement.

Zhitong Finance APP News, Fusen Pharmaceutical (01652.HK) announced that in the twelfth batch of national centralized procurement bidding for pharmaceuticals in China on July 31, 2026, the company plans to bid for four products: Nicardipine Injection (2ml: 2mg, 5ml: 5mg), Mesalazine Potassium Tablets (40mg, 80mg), Compound Potassium Hydrogen Phosphate Injection (5ml: Dipotassium Hydrogen Phosphate 1.12g and Potassium Hydrogen Phosphate (calculated as K2HPO4) 1.18g), Dydrogesterone Tablets (10mg).